Mogam Lab Logo

Introduction

We are committed to discovering and developing innovative new drugs based on scientific investigation and understanding of life phenomena.

Even if dust accumulates, it must settle  on this land.

Mogam Young-Sup Huh

Founding Chairman

Mogam Young-Sup Huh

MOGAM Institute Building

MOGAM Institute for Biomedical Research was established in 1984 with the support of Green Cross (now GC) as the first privately-funded nonprofit research foundation approved by the Ministry of Science and Technology.

At the time of its founding, we could have established a research institute in a better environment abroad or invested in other businesses. However, under the philosophy of "Even if dust accumulates, it must settle on this land," we established the institute in Korea.

This was a decision that embodied the will to contribute to society at a time when it was difficult to establish private research foundations.

For the past 40 years, we have contributed to the foundation of life science research in Korea. Building on our long-accumulated expertise in bio-drug development, we are now dedicated to developing innovative new drugs by integrating artificial intelligence (AI) technology.

Our mission is to develop breakthrough treatments for those suffering from diseases by combining accumulated expertise with AI technology.

From the beginning of research to a broader field of science

2021-현재

Present - 2021

FRONTIERFRONTIER

2020 - 2010

EVOLUTIONEVOLUTION

2009 - 1984

BEGINNINGBEGINNING
AI Drug Discovery Research

2024

06Dr. Hyun-Jin Shin appointed as the 12th Director

2022

04Dr. Sun Kim appointed as the 11th Director

2021

11Deputy Director Dr. Hyun-Jin Shin appointed, AI Drug Discovery Research Institute launched
Biopharmaceutical Research
Biopharmaceutical Research

2020

03Development of varicella vaccine 'Varicella Vaccine'
02Dr. Jae-Wook Jung appointed as the 10th Director

2018

09Dr. Eui-Cheol Cho appointed as the 9th Director

2016

05Renamed to Mogam Institute for Biomedical Research

2015

12Development of highly pathogenic avian influenza vaccine (H5N1)
11Development of quadrivalent flu vaccine 'GC FLU Quadrivalent'
0316th Korea New Drug Development Award - Technology Award (Neulapec)
02Dr. Seung-Hyun Choi appointed as the 8th Director

2014

08Development of neutropenia treatment 'Neulapec'

2013

04Dr. Eun-Chul Huh appointed as the 7th Director

2010

01Inauguration of 2nd Chairman Il-Seop Heo
Institute Foundation and Growth
Institute Foundation and Growth

2009

12Minister's Award at Health Industry Technology Awards (Anti-angiogenic cancer therapy)

2008

05Dr. Yup Yoon appointed as the 6th Director

2005

03Designated as WHO Collaborating Research Center (Vaccines and Diagnostics)

2000

11Dr. Du-Hong Park appointed as the 5th Director

1996

10Dr. Su-Il Jung appointed as the 4th Director

1995

02Designated as WHO Collaborating Research Center (Vaccines and Diagnostics)

1993

06Development of world's 2nd varicella vaccine 'Sudubox'

1992

05Dr. Hong-Mo Moon appointed as the 3rd Director

1990

07Development of world's first HFRS vaccine 'Hantavax'

1989

12Designated as WHO Collaborating Research Center (Vaccines and Diagnostics)
05Dr. Seung-Bok Baek appointed as the 2nd Director

1987

11Development of Korea's first AIDS (HIV-1) diagnostic reagent 'Hiviro Elisa'

1985

12Renamed to Mogam Biotechnology Research Institute

1984

05Dr. Kyung-Ho Kim appointed as the 1st Director
04Green Cross Research Institute established. 1st non-profit research corporation approved by MOST

Join MOGAM Institute's vision for humanity<br/>and the advancement of science.

Go to Donate